DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Mantovani A, Petracca G, Csermely A, Beatrice G, Targher G.
Sodium-Glucose cotransporter-2 inhibitors for treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
Metabolites 2020;
11 (01) 22
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.